Chadi re-invites Dave Feldman, senior software engineer and entrepreneur, and Ethan Weiss, MD, cardiologist at UC San Francisco, to rehash a Twitter argument on secondary prevention for heart attacks for patients with high LDL. Should patients receive statins or should they not? What does the data show and where is the controversy, if any? How does diet play a role? What about the infamous KETO diet? The guests discuss a couple of realistic hypothetical scenarios with different LDL receptor and metabolism variables. Dave shares an IRB-approved trial that he is leading to better understand high LDL that emerges from Keto and its impact on cardiac atherosclerotic disease.
This was a high-spirited debate where the host said so little and the guests were arguing respectfully about various views. Will there be a common ground? You must listen to find out.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
